December 25, 2014 5:20 PM ET

Biotechnology

Company Overview of Nile Therapeutics, Inc

Executive Profile

Peter Morgan Kash Ed.D

AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 14 different industries.

See Board Relationships
52--

Background

Mr. Peter Morgan Kash serves as the President and Chairman of Riverbank Capital Securities, Inc. He is an Adjunct Professor of Entrepreneurship at the Sy Syms School of Business. From 1989 to 1991, Mr. Kash served as an Associate Professor of Marketing at the Polytechnic University. Mr. Kash was a Senior Managing Director and Director of Paramount Capital Asset Management Inc. Mr. Morgan was a Partner at Two River Group Holdings, LLC. He co-founded the firm in September ...

Corporate Headquarters

63 Bovet Road
San Mateo, California 94402

United States

Phone: 650-918-7489
Fax: --

Board Members Memberships

Former Director
Former Vice Chairman and Vice Chairman of Innovative Drug Delivery Systems, Inc
Senior Managing Director and Director
Director
Former Director
Director
Director
Former Director
Former Director and Member of Audit Committee
Partner
Director
1998-N/A
Former Director and Chairman of Audit Committee
2004-2006
Former Director and Director of IDDS
2004-N/A
Former Director and Director of IDDS
2004-2007
Former Vice Chairman
2005-N/A
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2014-Present
Director

Education

MBA
Pace University
BS
State University of New York at Binghamton

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nile Therapeutics, Inc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.